{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T02:09:16Z","timestamp":1790906956178,"version":"4.1.0"},"reference-count":27,"publisher":"Wiley","issue":"10","license":[{"start":{"date-parts":[[2006,4,28]],"date-time":"2006-04-28T00:00:00Z","timestamp":1146182400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aliment Pharmacol Ther"],"published-print":{"date-parts":[[2006,5]]},"abstract":"<jats:sec><jats:title>Summary<\/jats:title><\/jats:sec><jats:sec><jats:title>Background<\/jats:title><jats:p>Alicaforsen is an antisense oligonucleotide designed to inhibit expression of human intercellular adhesion molecule 1. Previous clinical studies have demonstrated activity of alicaforsen enema in ulcerative colitis and pouchitis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Aim<\/jats:title><jats:p>To determine the minimally effective dosing regimen of alicaforsen enema in subjects with mild to moderate left\u2010sided ulcerative colitis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Randomized, placebo\u2010controlled, double\u2010blind, two\u2010dose ranging multicentre study. One hundred and twelve subjects were equally randomized to receive one of four alicaforsen enema regimens or placebo daily for 6\u2003weeks. Primary end point was Disease Activity Index at week 6. Secondary end points included evaluation of clinical improvement, relapse rates and durability of response. Analysis of data were performed on the intent\u2010to\u2010treat population.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>No significant difference was observed between treatment arms and placebo in the primary end point. A prolonged reduction in mean% Disease Activity Index relative to baseline was observed in the daily 240\u2003mg alicaforsen enema treatment arm in comparison with placebo from week 18 (51% vs. 18%, <jats:italic>P<\/jats:italic>\u2003=\u20030.04) to week 30 (50% vs. 11%, <jats:italic>P<\/jats:italic>\u2003=\u20030.03).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Alicaforsen enema was safe and well tolerated at all doses studied. The durability of the response to alicaforsen enema treatment may suggests a disease\u2010modifying effect.<\/jats:p><\/jats:sec>","DOI":"10.1111\/j.1365-2036.2006.02910.x","type":"journal-article","created":{"date-parts":[[2006,4,29]],"date-time":"2006-04-29T03:45:13Z","timestamp":1146282313000},"page":"1415-1425","source":"Crossref","is-referenced-by-count":105,"title":["A Phase II dose ranging, double\u2010blind, placebo\u2010controlled study of alicaforsen enema in subjects with acute exacerbation of mild to moderate left\u2010sided ulcerative colitis"],"prefix":"10.1111","volume":"23","author":[{"given":"S. J. H.","family":"VAN DEVENTER","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. K.","family":"WEDEL","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B. F.","family":"BAKER","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"XIA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"CHUANG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"JR","given":"P. B.","family":"MINER","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2006,4,28]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"crossref","first-page":"245","DOI":"10.4049\/jimmunol.137.1.245","article-title":"Induction by IL1 and interferon\u2010gamma: tissue distribution, biochemistry, and function of a natural adherence molecule (ICAM\u20101)","volume":"137","author":"Dustin ML","year":"1986","journal-title":"J Immunol"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.147.9.2913"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1038\/338512a0"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.144.12.4579"},{"key":"e_1_2_6_6_2","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.4049\/jimmunol.146.6.1773","article-title":"The accessory function of murine intercellular adhesion molecule\u20101 in T lymphocyte activation. Contributions of adhesion and co\u2010activation","volume":"146","author":"Kuhlman P","year":"1991","journal-title":"J Immunol"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1002\/eji.1830180423"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V84.7.2261.2261"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.163.9.5029"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(87)90104-8"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.111.6.3129"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2249.2000.01296.x"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1080\/01913120252959290"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.36.5.724"},{"key":"e_1_2_6_15_2","first-page":"988","article-title":"An ICAM\u20101 antisense oligonucleotide prevents and reverses dextran sulfate sodium\u2010induced colitis in mice","volume":"280","author":"Bennett CF","year":"1997","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_6_16_2","doi-asserted-by":"crossref","first-page":"3530","DOI":"10.4049\/jimmunol.152.7.3530","article-title":"Inhibition of endothelial cell\u2010leukocyte adhesion molecule expression with antisense oligonucleotides","volume":"152","author":"Bennett CF","year":"1994","journal-title":"J Immunol"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.med.55.091902.104408"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M311683200"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(98)70418-4"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2003.036160"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2004.01863.x"},{"key":"e_1_2_6_22_2","first-page":"1188","article-title":"Mesalamine capsules for treatment of active ulcerative colitis: results of a controlled trial. Pentasa Study Group","volume":"88","author":"Hanauer S","year":"1993","journal-title":"Am J Gastroenterol"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198712243172603"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0025-6196(12)60100-1"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(87)90621-4"},{"key":"e_1_2_6_26_2","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1155\/1990\/864194","article-title":"Maintaining remission in distal ulcerative colitis and ulcerative proctitis","volume":"4","author":"Miner PB","year":"1990","journal-title":"Can J Gastroenterol"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004836-198710000-00009"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2006.02837.x"}],"container-title":["Alimentary Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2036.2006.02910.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2036.2006.02910.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T15:46:54Z","timestamp":1697212014000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2036.2006.02910.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,4,28]]},"references-count":27,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2006,5]]}},"alternative-id":["10.1111\/j.1365-2036.2006.02910.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2036.2006.02910.x","archive":["Portico"],"relation":{},"ISSN":["0269-2813","1365-2036"],"issn-type":[{"value":"0269-2813","type":"print"},{"value":"1365-2036","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,4,28]]}}}